![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Dolan P.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.15, Iss.2, 1999-02, pp. : 119-127
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Valuing health-related quality of life
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Health-Related Quality of Life and Regulatory Issues in the US and Canada
By Glennie J.L.
PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Limited attention is paid to health-related quality-of-life (QOL) issues
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. :